Cracking The Code: Smarter Trial Design For Chronic Pain Analgesics

Developing effective analgesics for chronic pain is fraught with challenges: from trial design to placebo response management. While acute postoperative pain trials offer an efficient regulatory pathway, their results often don’t translate to success in chronic pain settings. This session explores the reasons why, and what sponsors can and should do about it.

As placebo response rates rise and site variability increases, it's time to rethink how trials are run, especially as inherent conflict between enrollment success and placebo response controls are often overlooked. Join us for a focused session on how strategic site selection, financial incentives, and smarter protocols can tip the odds in favor of demonstrating true analgesic efficiency.

Key discussion points include:

• Acute versus chronic pain trials: strengths, weaknesses, and FDA implications
• The placebo problem: why it's rising and how to counteract it
• Balance rapid enrollment with rigorous screening and training
• Data-driven site performance monitoring and incentive models
• Practical strategies to boost signal detection and trial success